DCM
DMTX

Driehaus Capital Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Driehaus Capital Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-253,772
Closed -$2.86M – 720
2015
Q4 		$2.86M Buy
+253,772
New +$3.21M 0.1% 229

Other funds holding DMTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Driehaus Capital Management's DMTX Position: Q1 2016 in Review

Driehaus Capital Management sold out of Dimension Therapeutics, Inc (DMTX) in Q1 2016, closing a stake of 253,772 shares — an estimated $2.86M sold.

Driehaus Capital Management first reported a position in DMTX in Q4 2015 and held it in 1 quarter. The position peaked at $2.86M in Q4 2015. 40 funds tracked by Wall St. Rank hold DMTX as of Q1 2016.

  • Driehaus Capital Management reported no remaining Dimension Therapeutics, Inc position as of Q1 2016 after selling out during the quarter.
  • Driehaus Capital Management sold 253,772 Dimension Therapeutics, Inc shares in Q1 2016, an estimated $2.86M.
  • Driehaus Capital Management first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 1 quarter.
  • Driehaus Capital Management's Dimension Therapeutics, Inc position peaked at $2.86M in Q4 2015.
  • 40 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q1 2016.

Based on Driehaus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.